(NASDAQ: TLRY) Tilray Brands's forecast annual revenue growth rate of 11.47% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.49%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.63%.
Tilray Brands's revenue in 2024 is $788,942,000.On average, 7 Wall Street analysts forecast TLRY's revenue for 2025 to be $760,032,022,308, with the lowest TLRY revenue forecast at $717,697,639,910, and the highest TLRY revenue forecast at $805,028,477,935. On average, 6 Wall Street analysts forecast TLRY's revenue for 2026 to be $815,852,949,857, with the lowest TLRY revenue forecast at $746,611,228,175, and the highest TLRY revenue forecast at $873,308,380,252.
In 2027, TLRY is forecast to generate $951,619,527,477 in revenue, with the lowest revenue forecast at $922,200,162,158 and the highest revenue forecast at $981,038,892,797.